McKesson

MCK

Market cap $106B

McKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The latest trading day saw McKesson (MCK) settling at $871.18, representing a +1.7% change from its previous close.

McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

In the closing of the recent trading day, McKesson (MCK) stood at $884.28, denoting a +1.37% move from the preceding trading day.

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CAH's turnaround gains traction with strong earnings growth and margin expansion, outpacing MCK's steady performance outlook.

McKesson's strong oncology, GLP-1, and biopharma growth fuel earnings momentum, but margin pressure and segment volatility remain key watch points.

IRVING, Texas--(BUSINESS WIRE)--Registration is now open for McKesson ideaShare 2026, a premier community pharmacy event for independent pharmacy owners and their teams.

Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.